Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters
Clinical and Experimental Reproductive Medicine · 01.12.2025 · 52 (4) · 376-385
DOI: 10.5653/cerm.2024.07675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Reproductive Medicine, erschienen am 01.12.2025. Verfasst von Young Jae Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the long-term effects of dutasteride on male fertility and determine the cutoff treatment duration that causes significant and persistent decreases in semen parameters.
Methods
This was a single-center, randomized, controlled study that evaluated 200 men (ages 28 to 39 years). Forty men were allocated to each study group, divided according to the duration of dutasteride treatment, as follows: 24 months (group 5). All subjects received dutasteride 0.5 mg/day for management of androgenetic alopecia then discontinued dutasteride for 6 months.
Results
The baseline mean testosterone level in the study subjects was 4.8 ng/mL. No significant differences were found between study groups in sperm concentration, normal morphology, and vitality. Semen volume and sperm total/progressive motility were significantly reduced as the duration of dutasteride treatment increased. All study groups showed an increase in total sperm motility and semen volume after discontinuation of dutasteride. Compared with group 1, groups 2–5 showed significant decreases in semen volume and sperm total motility, with the odds ratios becoming smaller as the duration of dutasteride treatment increased. Receiver operating characteristic analysis showed the cutoff values for persistent impairment of semen volume and total sperm motility to be 17.8 and 20.3 months, respectively.
Conclusion
Long-term use of dutasteride may lead to male infertility by persistently impairing semen volume and sperm motility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
- Department of Andrology, Fertility Center of CHA Bundang Medical Center, Seongnam, Korea.
Zitieren
APA
Kim, Y. J., Lee, S. R., & Yu, Y. D. (2025). Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters. Clinical and Experimental Reproductive Medicine, 52(4), 376-385. https://doi.org/10.5653/cerm.2024.07675
Vancouver
Kim YJ, Lee SR, Yu YD. Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters. Clinical and Experimental Reproductive Medicine. 2025;52(4):376-385. doi:10.5653/cerm.2024.07675
BibTeX
@article{Kim2025,
author = {Kim, Young Jae and Lee, Seoung Ryeol and Yu, Young Dong},
title = {Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters},
journal = {Clinical and Experimental Reproductive Medicine},
year = {2025},
volume = {52},
number = {4},
pages = {376--385},
doi = {10.5653/cerm.2024.07675}
}
EUVIMED